These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 3502683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Activity of ornithine decarboxylase and creatine kinase in soft and hard tissue of vitamin D-deficient chicks following parenteral application of 1,25-dihydroxyvitamin D3 or 24R,25-dihydroxyvitamin D3.
    Ittel TH, Ross FP, Norman AW.
    J Bone Miner Res; 1986 Feb; 1(1):23-31. PubMed ID: 3509739
    [Abstract] [Full Text] [Related]

  • 5. Healing of rachitic lesions in chicks by 24R,25-dihydroxycholecalciferol administered locally into bone.
    Lidor C, Atkin I, Ornoy A, Dekel S, Edelstein S.
    J Bone Miner Res; 1987 Apr; 2(2):91-8. PubMed ID: 3502667
    [Abstract] [Full Text] [Related]

  • 6. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN, Blazheevich NV, Kaplanskiĭ AS, Shvets VN, Belakovskiĭ MS.
    Vopr Med Khim; 1987 Apr; 33(1):100-7. PubMed ID: 3495067
    [Abstract] [Full Text] [Related]

  • 7. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Apr; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 8. [Effect of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth and remodeling of rat bones during hypokinesia (histomorphometric study)].
    Kabitskaia OE, Savik ZF, Kaplanskiĭ AS, Shvets VN, Sergeev IN.
    Kosm Biol Aviakosm Med; 1984 Apr; 18(4):49-55. PubMed ID: 6332944
    [Abstract] [Full Text] [Related]

  • 9. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture.
    Hale LV, Kemick ML, Wuthier RE.
    J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The influence of early parathyroidectomy on aluminum-induced rickets in growing uremic rats.
    Vukicević S, Stavljenić A, Boll T, Cervar M, Degenhardt C, Mihaljević T, Krempien B.
    Bone Miner; 1989 May; 6(2):125-39. PubMed ID: 2765704
    [Abstract] [Full Text] [Related]

  • 13. Reduced deposition of aluminium in trabecular bone of uraemic rats treated with dihydroxylated vitamin D metabolites.
    Ittel TH, Hofstädter F, Gladziwa U, Sieberth HG.
    Nephrol Dial Transplant; 1989 May; 4(11):957-65. PubMed ID: 2516887
    [Abstract] [Full Text] [Related]

  • 14. Effect of dietary calcium on the response of bone to 1,25 (OH)2D3.
    Boyce RW, Weisbrode SE.
    Lab Invest; 1983 Jun; 48(6):683-9. PubMed ID: 6687909
    [Abstract] [Full Text] [Related]

  • 15. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
    Lieuallen WG, Weisbrode SE.
    J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
    [Abstract] [Full Text] [Related]

  • 16. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets.
    Kraft D, Offermann G, Steldinger R, Gawlik D.
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788
    [Abstract] [Full Text] [Related]

  • 17. Effects of vitamin D metabolites on healing of low phosphate, vitamin D-deficient induced rickets in rats.
    Atkin I, Pita JC, Ornoy A, Agundez A, Castiglione G, Howell DS.
    Bone; 1985 Dec; 6(2):113-23. PubMed ID: 3874635
    [Abstract] [Full Text] [Related]

  • 18. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 19. Light- and electron-microscopic evaluation of the effects of 1,25-dihydroxyvitamin D3 on bone of thyroparathyroidectomized rats.
    Weisbrode SE, Capen CC, Norman AW.
    Am J Pathol; 1979 Nov; 97(2):247-60. PubMed ID: 525673
    [Abstract] [Full Text] [Related]

  • 20. 1a,25-Dihydroxyvitamin D3 stimulates alkaline phosphatase activity and inhibits soft-tissue proliferation in implants of bone matrix.
    Vukicević S, Stavljenić A, Bagi C, Vujicić G, Kracun I, Winter I.
    Clin Orthop Relat Res; 1985 Jun; (196):285-91. PubMed ID: 3873307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.